日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancer

抑制N-肉豆蔻酰转移酶活性可促进前列腺癌中的雄激素受体降解

Omar Awad Alsaidan, Emmanuel Onobun, Chenming Ye, Lei Lou, Zanna Beharry, Zhong-Ru Xie, Iryna Lebedyeva, David Crich, Houjian Cai

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti-PD-1 resistance

靶向TREM1可通过抑制髓源性抑制细胞和抑制抗PD-1耐药性来增强抗肿瘤T细胞免疫。

Ashwin Ajith ,Kenza Mamouni ,Daniel D Horuzsko ,Abu Musa ,Amiran K Dzutsev ,Jennifer R Fang ,Ahmed Chadli ,Xingguo Zhu ,Iryna Lebedyeva ,Giorgio Trinchieri ,Anatolij Horuzsko

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases

T2加权和DWI MRI的放射组学特征可预测结直肠癌肝转移瘤的肿瘤缺氧情况

Bodalal, Zuhir; Bogveradze, Nino; Ter Beek, Leon C; van den Berg, Jose G; Sanders, Joyce; Hofland, Ingrid; Trebeschi, Stefano; Groot Lipman, Kevin B W; Storck, Koen; Hong, Eun Kyoung; Lebedyeva, Natalya; Maas, Monique; Beets-Tan, Regina G H; Gomez, Fernando M; Kurilova, Ieva

A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice

非系统性磷酸二酯酶-5 抑制剂可抑制小鼠结肠增殖

Avelina Lee, Iryna Lebedyeva, Wenbo Zhi, Vani Senthil, Herjot Cheema, Michael W Brands, Weston Bush, Nevin A Lambert, Madeline Snipes, Darren D Browning

Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study

胶质母细胞瘤肿瘤微环境变化与靶向肿瘤微环境治疗疗效的关系:一项初步研究

Sehar Ali ,Thaiz F Borin ,Raziye Piranlioglu ,Roxan Ara ,Iryna Lebedyeva ,Kartik Angara ,Bhagelu R Achyut ,Ali Syed Arbab ,Mohammad H Rashid

SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth

SUV39H1通过调控人结肠癌细胞凋亡和细胞周期促进肿瘤生长

Lu, Chunwan; Klement, John D; Yang, Dafeng; Albers, Thomas; Lebedyeva, Iryna O; Waller, Jennifer L; Liu, Kebin

SUV39H1 Represses the Expression of Cytotoxic T-Lymphocyte Effector Genes to Promote Colon Tumor Immune Evasion

SUV39H1抑制细胞毒性T淋巴细胞效应基因的表达,从而促进结肠肿瘤的免疫逃逸

Chunwan Lu ,Dafeng Yang ,John D Klement ,Il Kyu Oh ,Natasha M Savage ,Jennifer L Waller ,Aaron H Colby ,Mark W Grinstaff ,Nicholas H Oberlies ,Cedric J Pearce ,Zhiliang Xie ,Samuel K Kulp ,Christopher C Coss ,Mitch A Phelps ,Thomas Albers ,Iryna O Lebedyeva ,Kebin Liu

Corrigendum to "CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma" Neoplasia, October 2018, Volume 20, Issue 10, Pages 1070-1082

更正“表达CXCR2的肿瘤细胞驱动抗血管生成疗法耐药性胶质母细胞瘤的血管拟态” Neoplasia,2018年10月,第20卷,第10期,第1070-1082页

Angara, Kartik; Borin, Thaiz F; Rashid, Mohammad H; Lebedyeva, Iryna; Ara, Roxan; Lin, Ping-Chang; Iskander, Asm; Bollag, Roni J; Achyut, Bhagelu R; Arbab, Ali S

Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression

药理学上针对支架蛋白 FRS2α 的肉豆蔻酰化可抑制 FGF/FGFR 介导的致癌信号传导和肿瘤进展

Qianjin Li, Omar Awad Alsaidan, Yongjie Ma, Sungjin Kim, Junchen Liu, Thomas Albers, Kebin Liu, Zanna Beharry, Shaying Zhao, Fen Wang, Iryna Lebedyeva, Houjian Cai

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma

表达 CXCR2 的肿瘤细胞在抗血管生成治疗耐药性胶质母细胞瘤中驱动血管模拟

Kartik Angara, Thaiz F Borin, Mohammad H Rashid, Iryna Lebedyeva, Roxan Ara, Ping-Chang Lin, Asm Iskander, Roni J Bollag, Bhagelu R Achyut, Ali S Arbab